Sponsor study identifier
observational
71
1 country
1
Study Start
February 2011
Actual (reported)Primary Completion
December 2016
Actual (reported)Study Completion
December 2017
Actual (reported)The present study aimed to examine face and object perception processes in schizophrenic patients. Schizophrenia is associated with deficits in visual processing that represent a key feature in the disorder. Previous studies have shown that schizophrenics exhibit deficits in a variety of facial-processing tasks (e.g., face recognition, recognition of facial expressions), that may severely hinder the patients' interpersonal and social skills. Some investigators have attributed these deficits to impairments in configural processing in schizophrenia. That is, an impairment in the ability to process the spatial relations between the constituent parts of a configuration (e.g., the spacing between the eyes of a given face). To date, studies aimed to investigate this possibility (e.g., Schwartz et al., 2002; Yong-Wook et al., 2008) yielded conflicting results. Additionally, it is not yet clear whether the hypothesized impairment in configural processing is restricted to faces, or whether it is more general in nature and applies to objects as well.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2, 2010
Actual (reported)February 2011
Actual (reported)February 17, 2011
Actual (reported)December 2016
Actual (reported)December 2017
Actual (reported)Performance in Experiment 1: Probability of Global Perception (%)
The probabilities (in percentage) of choosing the comparison figure having the same configuration as the standard figure. That is, the ratio between the number of trials in which participants chose the comparison figure as having the same configuration as the standard figure, and the total number of trials.
2 weeks.
Performance in Experiment 2: Response Time (milliseconds)
Response Time in milliseconds; will be measured from stimulus onset on screen until prticipant's response.
2 weeks.
Performance in Experiment 2: Error Rate (%)
Percentage of Errors; The ratio between number of errors and the total number of responses.
2 weeks.
patients diagnosed with schizophrenia or schizo-affective disorder according to DSM4 and normal population with no psychiatric history
Haemek Medical Center
Afula, Israel
Boaz Bloch, MD
Haemek Mediacl Center
Alon Reshef, MD
haemek medical center
Rama Amishav, Phd
haemek medical center
71 participants (actual enrollment reported by the registry).
First Submitted
December 2, 2010
First Posted
February 17, 2011
Study Start
February 2011
Actual (reported)Shiatsu Adjuvant Therapy And Placebo For Schizophrenia
Contact the study team to confirm eligibility.
Primary Completion
December 2016
Actual (reported)Study Completion
December 2017
Actual (reported)Last Updated
February 17, 2020
Record last verified: 2020-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: